Breaking News Instant updates and real-time market news.

PFE

Pfizer

$34.69 /

-0.03 (-0.09%)

08:08
02/17/21
02/17
08:08
02/17/21
08:08

Imcyse raises additional EUR21.3M in Series B financing round

Imcyse announced that it has concluded a Series B extension financing round, raising EUR21.3M. Participants of the new round included existing investors, Biogenosis, Epimede, LSP, Noshaq, Societe Regionale d'Investissement de Wallonie, Societe Federale de Participations et d'Investissement and KU Leuven. Pfizer also participated as Imcyse's newest investor taking an equity stake in the Company as part of the license agreement for Imcyse's Rheumatoid Arthritis program based on the Company's Imotope technology announced on February 3, 2021. Proceeds from the latest financing round will be used to accelerate the advancement of several first-in-class targeted disease modifying immunotherapeutics, developing a robust and diverse clinical pipeline. In accordance with Imcyse's corporate strategy, the Company remains open to new partnerships and investors to further support its development and expansion into the U.S.

  • 22

    Feb

  • 01

    Mar

  • 24

    Mar

  • 29

    Dec

PFE Pfizer
$34.69 /

-0.03 (-0.09%)

02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
02/03/21 Mizuho
Pfizer price target lowered to $42 from $44 at Mizuho
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink

TODAY'S FREE FLY STORIES

Hot Stocks
MoneyGram announces partnership with Sigue Corporation » 11:34
04/13/21
04/13
11:34
04/13/21
11:34
MGI

MoneyGram

$6.46 /

-0.01 (-0.15%)

MoneyGram International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGI MoneyGram
$6.46 /

-0.01 (-0.15%)

MGI MoneyGram
$6.46 /

-0.01 (-0.15%)

02/25/21 Barclays
MoneyGram price target raised to $6 from $4.50 at Barclays
01/19/21 DA Davidson
DA Davidson doesn't see Walmart adding Western Union to hurt Euronet materially
01/11/21 Northland
MoneyGram upgraded to Outperform from Market Perform at Northland
08/03/20 Evercore ISI
MoneyGram upgraded to In Line from Underperform at Evercore ISI
MGI MoneyGram
$6.46 /

-0.01 (-0.15%)

MGI MoneyGram
$6.46 /

-0.01 (-0.15%)

MGI MoneyGram
$6.46 /

-0.01 (-0.15%)

MGI MoneyGram
$6.46 /

-0.01 (-0.15%)

Recommendations
Novocure price target raised to $215 from $135 at Wells Fargo » 11:34
04/13/21
04/13
11:34
04/13/21
11:34
NVCR

Novocure

$183.50 /

+51.89 (+39.43%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$183.50 /

+51.89 (+39.43%)

NVCR Novocure
$183.50 /

+51.89 (+39.43%)

10:48 Today Guggenheim
Zai Lab price target raised to $250 from $165 at Guggenheim
09:26 Today Piper Sandler
DMC review 'clear positive' for Novocure, says Piper Sandler
03/01/21 Mizuho
Novocure price target raised to $175 from $150 at Mizuho
02/25/21 Piper Sandler
'Overreaction to downside' in Novocure a buying opportunity, says Piper Sandler
NVCR Novocure
$183.50 /

+51.89 (+39.43%)

NVCR Novocure
$183.50 /

+51.89 (+39.43%)

Periodicals
GM shortens expected downtime at Tennessee plant, CNBC reports » 11:28
04/13/21
04/13
11:28
04/13/21
11:28
GM

General Motors

$58.37 /

-1.295 (-2.17%)

General Motors is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$58.37 /

-1.295 (-2.17%)

GM General Motors
$58.37 /

-1.295 (-2.17%)

04/05/21
Fly Intel: Top five analyst initiations
04/05/21 Wells Fargo
General Motors initiated with an Overweight at Wells Fargo
03/29/21 Jefferies
General Motors price target raised to $62 from $50 at Jefferies
03/24/21 Morgan Stanley
American Axle downgraded to Underweight on ICE phase out risk at Morgan Stanley
GM General Motors
$58.37 /

-1.295 (-2.17%)

GM General Motors
$58.37 /

-1.295 (-2.17%)

GM General Motors
$58.37 /

-1.295 (-2.17%)

GM General Motors
$58.37 /

-1.295 (-2.17%)

Options
iQiyi call volume above normal and directionally bullish » 11:25
04/13/21
04/13
11:25
04/13/21
11:25
IQ

iQIYI

$16.69 /

+0.515 (+3.18%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IQ iQIYI
$16.69 /

+0.515 (+3.18%)

IQ iQIYI
$16.69 /

+0.515 (+3.18%)

02/22/21 KeyBanc
iQIYI upgraded to Overweight from Sector Weight at KeyBanc
02/18/21
Fly Intel: Top five analyst downgrades
02/18/21 JPMorgan
iQIYI downgraded to Underweight from Neutral at JPMorgan
01/19/21 UBS
iQIYI downgraded to Neutral from Buy at UBS
IQ iQIYI
$16.69 /

+0.515 (+3.18%)

  • 17
    Dec
IQ iQIYI
$16.69 /

+0.515 (+3.18%)

IQ iQIYI
$16.69 /

+0.515 (+3.18%)

IQ iQIYI
$16.69 /

+0.515 (+3.18%)

Conference/Events
Cowen Washington strategist to hold analyst/industry conference call » 11:25
04/13/21
04/13
11:25
04/13/21
11:25

Washington Strategist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
KKR planning to outbid CVC for Toshiba with offer in excess of $20B, FT reports » 11:23
04/13/21
04/13
11:23
04/13/21
11:23
TOSYY

Toshiba

$20.85 /

+0.03 (+0.14%)

, KKR

KKR

$52.09 /

+0.08 (+0.15%)

KKR (KKR) is planning to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TOSYY Toshiba
$20.85 /

+0.03 (+0.14%)

KKR KKR
$52.09 /

+0.08 (+0.15%)

TOSYY Toshiba
$20.85 /

+0.03 (+0.14%)

03/19/21 SMBC Nikko
Toshiba upgraded to Outperform from Neutral at SMBC Nikko
02/19/21 Citi
Toshiba resumed with a Neutral at Citi
04/22/20 UBS
Toshiba downgraded to Neutral from Buy at UBS
KKR KKR
$52.09 /

+0.08 (+0.15%)

04/09/21 DA Davidson
Box price target lowered to $22 from $25 at DA Davidson
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
04/07/21 Seaport Global
Seaport downgrades Sempra Energy to Neutral after 'good, not great' SIP deal
KKR KKR
$52.09 /

+0.08 (+0.15%)

  • 11
    Nov
TOSYY Toshiba
$20.85 /

+0.03 (+0.14%)

KKR KKR
$52.09 /

+0.08 (+0.15%)

TOSYY Toshiba
$20.85 /

+0.03 (+0.14%)

KKR KKR
$52.09 /

+0.08 (+0.15%)

Recommendations
Stelco Holdings price target raised to C$34 from C$29 at RBC Capital » 11:20
04/13/21
04/13
11:20
04/13/21
11:20
STZHF

Stelco Holdings

$23.05 /

-0.23 (-0.99%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STZHF Stelco Holdings
$23.05 /

-0.23 (-0.99%)

03/31/21 Scotiabank
Stelco Holdings price target raised to C$32 from C$30 at Scotiabank
02/24/21 RBC Capital
Stelco Holdings upgraded to Outperform from Sector Perform at RBC Capital
02/22/21 Exane BNP Paribas
Stelco Holdings upgraded to Outperform from Neutral at Exane BNP Paribas
02/03/21 Credit Suisse
Stelco Holdings upgraded to Outperform from Neutral at Credit Suisse
General news
Treasury announced an $80 B set of 4- and 8-week bill auctions for Thursday » 11:20
04/13/21
04/13
11:20
04/13/21
11:20
$ECON

Economic Data

/

+

Treasury announced an $80…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    Ascot Resources price target lowered to C$1.85 from C$2 at Desjardins » 11:19
    04/13/21
    04/13
    11:19
    04/13/21
    11:19
    AOTVF

    Ascot Resources

    /

    +

    Desjardins analyst David…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    AOTVF Ascot Resources
    /

    +

    AOTVF Ascot Resources
    /

    +

    12/11/20 Raymond James
    Ascot Resources price target raised to C$2 from C$1.75 at Raymond James
    09/25/20 Raymond James
    Ascot Resources initiated with a Strong Buy at Raymond James
    04/29/20 Roth Capital
    Roth Capital bullish on Ascot Resources, initiates with a Buy
    04/29/20 Roth Capital
    Ascot Resources initiated with a Buy at Roth Capital
    Recommendations
    Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler » 11:19
    04/13/21
    04/13
    11:19
    04/13/21
    11:19
    RIGL

    Rigel Pharmaceuticals

    $3.50 /

    +0.405 (+13.09%)

    After Rigel…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    RIGL Rigel Pharmaceuticals
    $3.50 /

    +0.405 (+13.09%)

    RIGL Rigel Pharmaceuticals
    $3.50 /

    +0.405 (+13.09%)

    02/18/21 H.C. Wainwright
    Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
    02/18/21 Piper Sandler
    Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler
    11/09/20
    Fly Intel: Top five analyst downgrades
    11/09/20 JPMorgan
    Rigel Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan
    RIGL Rigel Pharmaceuticals
    $3.50 /

    +0.405 (+13.09%)

    RIGL Rigel Pharmaceuticals
    $3.50 /

    +0.405 (+13.09%)

    Conference/Events
    Immunocore participates in a conference call with JPMorgan » 11:19
    04/13/21
    04/13
    11:19
    04/13/21
    11:19
    IMCR

    Immunocore

    $34.25 /

    +2.03 (+6.30%)

    SMid Cap Biotech Analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    IMCR Immunocore
    $34.25 /

    +2.03 (+6.30%)

    IMCR Immunocore
    $34.25 /

    +2.03 (+6.30%)

    03/02/21 Jefferies
    Immunocore initiated with a Buy at Jefferies
    03/02/21 JPMorgan
    Immunocore initiated with an Overweight at JPMorgan
    03/02/21 Goldman Sachs
    Immunocore initiated with a Neutral at Goldman Sachs
    IMCR Immunocore
    $34.25 /

    +2.03 (+6.30%)

    • 05
      Feb
    IMCR Immunocore
    $34.25 /

    +2.03 (+6.30%)

    Technical Analysis
    NASDAQ market internals summary » 11:17
    04/13/21
    04/13
    11:17
    04/13/21
    11:17
    $NSD

    NASDAQ Market Internals

    /

    +

    Volume is above average…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    $NSD NASDAQ Market Internals
    /

    +

    Conference/Events
    Akero Therapeutics participates in a conference call with JPMorgan » 11:16
    04/13/21
    04/13
    11:16
    04/13/21
    11:16
    AKRO

    Akero Therapeutics

    $26.88 /

    -0.29 (-1.07%)

    SMid Cap Biotech Analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    AKRO Akero Therapeutics
    $26.88 /

    -0.29 (-1.07%)

    AKRO Akero Therapeutics
    $26.88 /

    -0.29 (-1.07%)

    03/23/21 H.C. Wainwright
    Akero Therapeutics price target raised to $68 from $61 at H.C. Wainwright
    03/23/21 Chardan
    Akero NASH data 'very exciting outcome,' says Chardan
    03/17/21 Chardan
    Akero Therapeutics price target raised to $81 from $79 at Chardan
    02/26/21 Guggenheim
    Akero Therapeutics initiated with a Buy at Guggenheim
    AKRO Akero Therapeutics
    $26.88 /

    -0.29 (-1.07%)

    • 08
      Jul
    AKRO Akero Therapeutics
    $26.88 /

    -0.29 (-1.07%)

    Technical Analysis
    NYSE market internals summary » 11:16
    04/13/21
    04/13
    11:16
    04/13/21
    11:16
    $NYE

    NYSE Market Internals

    /

    +

    Volume is average for…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    $NYE NYSE Market Internals
    /

    +

    Recommendations
    Western Forest price target raised to C$2.50 from C$1.90 at CIBC » 11:15
    04/13/21
    04/13
    11:15
    04/13/21
    11:15
    WFSTF

    Western Forest

    $1.59 /

    -0.0029 (-0.18%)

    CIBC analyst Hamir Patel…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    WFSTF Western Forest
    $1.59 /

    -0.0029 (-0.18%)

    03/03/21 Scotiabank
    Western Forest price target raised to C$2.25 from C$2 at Scotiabank
    02/22/21 RBC Capital
    Western Forest price target raised to C$2 from C$1.50 at RBC Capital
    02/22/21 TD Securities
    Western Forest price target raised to C$2 from C$1.75 at TD Securities
    02/19/21 Scotiabank
    Western Forest price target raised to C$2 from C$1.50 at Scotiabank
    Recommendations
    West Fraser Timber price target raised to C$135 from C$120 at CIBC » 11:15
    04/13/21
    04/13
    11:15
    04/13/21
    11:15
    WFG

    West Fraser Timber

    $82.77 /

    +0.95 (+1.16%)

    CIBC analyst Hamir Patel…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    WFG West Fraser Timber
    $82.77 /

    +0.95 (+1.16%)

    04/07/21 Scotiabank
    West Fraser Timber price target raised to C$120 from C$106 at Scotiabank
    03/26/21 TD Securities
    West Fraser Timber upgraded to Action List Buy from Buy at TD Securities
    03/03/21 Scotiabank
    West Fraser Timber price target raised to C$106 from C$103 at Scotiabank
    02/16/21 TD Securities
    West Fraser Timber price target raised to $91 from $86 at TD Securities
    Options
    Charles Schwab put volume heavy and directionally bearish » 11:15
    04/13/21
    04/13
    11:15
    04/13/21
    11:15
    SCHW

    Charles Schwab

    $67.09 /

    -0.63 (-0.93%)

    Bearish flow noted in…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SCHW Charles Schwab
    $67.09 /

    -0.63 (-0.93%)

    SCHW Charles Schwab
    $67.09 /

    -0.63 (-0.93%)

    04/09/21
    Fly Intel: Top five analyst upgrades
    04/09/21 Jefferies
    Charles Schwab price target raised to $76 from $70 at Jefferies
    04/09/21 JPMorgan
    Charles Schwab price target raised to $81 from $79 at JPMorgan
    04/09/21 Deutsche Bank
    Charles Schwab price target raised to $79 from $77 at Deutsche Bank
    SCHW Charles Schwab
    $67.09 /

    -0.63 (-0.93%)

    SCHW Charles Schwab
    $67.09 /

    -0.63 (-0.93%)

    SCHW Charles Schwab
    $67.09 /

    -0.63 (-0.93%)

    SCHW Charles Schwab
    $67.09 /

    -0.63 (-0.93%)

    Recommendations
    Toromont Industries price target raised to C$100 from C$95 at CIBC » 11:14
    04/13/21
    04/13
    11:14
    04/13/21
    11:14
    TMTNF

    Toromont Industries

    $77.45 /

    -0.33 (-0.42%)

    CIBC analyst Jacob Bout…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    TMTNF Toromont Industries
    $77.45 /

    -0.33 (-0.42%)

    04/06/21 Scotiabank
    Toromont Industries price target raised to C$115 from C$100 at Scotiabank
    04/06/21 Scotiabank
    Scotiabank upgrades Toromont to Outperform, says premium valuation warranted
    04/05/21 Scotiabank
    Toromont Industries upgraded to Outperform from Sector Perform at Scotiabank
    02/16/21 TD Securities
    Toromont Industries price target raised to C$98 from C$95 at TD Securities
    On The Fly
    Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine » 11:12
    04/13/21
    04/13
    11:12
    04/13/21
    11:12
    JNJ

    Johnson & Johnson

    $157.42 /

    -4.165 (-2.58%)

    , MRNA

    Moderna

    $150.11 /

    +10.82 (+7.77%)

    , PFE

    Pfizer

    $37.14 /

    +0.16 (+0.43%)

    Shares of Johnson &…

    ShowHide Related Items >><<
    JNJ Johnson & Johnson
    $157.42 /

    -4.165 (-2.58%)

    MRNA Moderna
    $150.11 /

    +10.82 (+7.77%)

    PFE Pfizer
    $37.14 /

    +0.16 (+0.43%)

    JNJ Johnson & Johnson
    $157.42 /

    -4.165 (-2.58%)

    09:34 Today Goldman Sachs
    J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
    09:33 Today Morgan Stanley
    Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
    09:21 Today JPMorgan
    Vaccine pause 'incremental negative' for J&J, says JPMorgan
    08:15 Today Piper Sandler
    Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
    MRNA Moderna
    $150.11 /

    +10.82 (+7.77%)

    09:33 Today Morgan Stanley
    Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
    08:15 Today Piper Sandler
    Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
    04/07/21 Jefferies
    Catalent pact with Moderna removes potential overhang, says Jefferies
    03/15/21 Piper Sandler
    Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study
    PFE Pfizer
    $37.14 /

    +0.16 (+0.43%)

    09:33 Today Morgan Stanley
    Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
    09:21 Today JPMorgan
    Vaccine pause 'incremental negative' for J&J, says JPMorgan
    04/09/21
    Pfizer to host conference call
    04/06/21 RBC Capital
    Pfizer transferred with a Sector Perform at RBC Capital
    JNJ Johnson & Johnson
    $157.42 /

    -4.165 (-2.58%)

    MRNA Moderna
    $150.11 /

    +10.82 (+7.77%)

    PFE Pfizer
    $37.14 /

    +0.16 (+0.43%)

    • 19
      May
    JNJ Johnson & Johnson
    $157.42 /

    -4.165 (-2.58%)

    MRNA Moderna
    $150.11 /

    +10.82 (+7.77%)

    PFE Pfizer
    $37.14 /

    +0.16 (+0.43%)

    JNJ Johnson & Johnson
    $157.42 /

    -4.165 (-2.58%)

    MRNA Moderna
    $150.11 /

    +10.82 (+7.77%)

    PFE Pfizer
    $37.14 /

    +0.16 (+0.43%)

    JNJ Johnson & Johnson
    $157.42 /

    -4.165 (-2.58%)

    MRNA Moderna
    $150.11 /

    +10.82 (+7.77%)

    PFE Pfizer
    $37.14 /

    +0.16 (+0.43%)

    Conference/Events
    JPMorgan biotech/pharma analysts hold an analyst/industry conference call » 11:10
    04/13/21
    04/13
    11:10
    04/13/21
    11:10

    Biotechnology Analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Recommendations
    Stella-Jones price target raised to C$60 from C$57 at CIBC » 11:10
    04/13/21
    04/13
    11:10
    04/13/21
    11:10
    STLJF

    Stella-Jones

    $41.00 /

    + (+0.00%)

    CIBC analyst Hamir Patel…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    STLJF Stella-Jones
    $41.00 /

    + (+0.00%)

    03/12/21 Desjardins
    Stella-Jones price target raised to C$61 from C$55 at Desjardins
    03/11/21 CIBC
    Stella-Jones price target raised to C$57 from C$54 at CIBC
    03/11/21 RBC Capital
    Stella-Jones price target raised to C$55 from C$53 at RBC Capital
    03/11/21 TD Securities
    Stella-Jones price target raised to C$59 from C$56 at TD Securities
    Recommendations
    Stantec price target raised to C$62 from C$56 at CIBC » 11:09
    04/13/21
    04/13
    11:09
    04/13/21
    11:09
    STN

    Stantec

    $45.10 /

    -0.62 (-1.36%)

    CIBC analyst Jacob Bout…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    STN Stantec
    $45.10 /

    -0.62 (-1.36%)

    STN Stantec
    $45.10 /

    -0.62 (-1.36%)

    03/01/21 Desjardins
    Stantec price target raised to C$57 from C$56 at Desjardins
    02/26/21 Canaccord
    Stantec price target raised to C$55 from C$50 at Canaccord
    02/26/21 BMO Capital
    Stantec price target raised to C$56 from C$50 at BMO Capital
    02/26/21 RBC Capital
    Stantec price target raised to C$48 from C$45 at RBC Capital
    STN Stantec
    $45.10 /

    -0.62 (-1.36%)

    Hot Stocks
    Boeing reports 196 gross commercial airplane orders in March » 11:09
    04/13/21
    04/13
    11:09
    04/13/21
    11:09
    BA

    Boeing

    $248.68 /

    -0.98 (-0.39%)

    Boeing reported airplane…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BA Boeing
    $248.68 /

    -0.98 (-0.39%)

    BA Boeing
    $248.68 /

    -0.98 (-0.39%)

    04/09/21 Baird
    Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
    03/29/21 Goldman Sachs
    Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
    03/19/21 Susquehanna
    Boeing price target raised to $300 from $250 at Susquehanna
    03/15/21 Morgan Stanley
    Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley
    BA Boeing
    $248.68 /

    -0.98 (-0.39%)

    BA Boeing
    $248.68 /

    -0.98 (-0.39%)

    BA Boeing
    $248.68 /

    -0.98 (-0.39%)

    BA Boeing
    $248.68 /

    -0.98 (-0.39%)

    Hot Stocks
    Izea reports QTD managed services bookings exceeding bookings for year-ago » 11:09
    04/13/21
    04/13
    11:09
    04/13/21
    11:09
    IZEA

    Izea

    $5.03 /

    -0.275 (-5.18%)

    IZEA Worldwide announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    IZEA Izea
    $5.03 /

    -0.275 (-5.18%)

    IZEA Izea
    $5.03 /

    -0.275 (-5.18%)

    04/06/21 Ladenburg
    Izea upgraded to Neutral at Ladenburg as bookings accelerate
    04/06/21 Ladenburg
    Izea upgraded to Neutral from Sell at Ladenburg
    01/26/21
    Fly Intel: Top five analyst downgrades
    01/26/21 Ladenburg
    Ladenburg downgrades Izea to Sell on 'excessive' valuation
    IZEA Izea
    $5.03 /

    -0.275 (-5.18%)

    IZEA Izea
    $5.03 /

    -0.275 (-5.18%)

    Recommendations
    SNC-Lavalin price target raised to C$34 from C$31 at CIBC » 11:08
    04/13/21
    04/13
    11:08
    04/13/21
    11:08
    SNCAF

    SNC-Lavalin

    $21.72 /

    -0.10392 (-0.48%)

    CIBC analyst Jacob Bout…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SNCAF SNC-Lavalin
    $21.72 /

    -0.10392 (-0.48%)

    03/11/21 Desjardins
    SNC-Lavalin price target lowered to C$37 from C$38 at Desjardins
    03/10/21 National Bank
    SNC-Lavalin price target lowered to C$33.50 from C$34.50 at National Bank
    03/10/21 Scotiabank
    SNC-Lavalin price target lowered to C$39 from C$42 at Scotiabank
    03/09/21 Desjardins
    SNC-Lavalin price target raised to C$38 from C$34 at Desjardins

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.